FDA Approves Natco’s Generic Glycopyrrolate Tablets


Natco Pharma has announced receiving FDA approval for a generic version of  Glycopyrrolate tablets. The tablets will be manufactured at the company’s Kothur dosage facility located near Hyderabad. The tablets will be sold in 1 mg and 2 mg dosages.

Read the source article at Business Standard

Leave a Reply

Your email address will not be published. Required fields are marked *

You may use these HTML tags and attributes: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <strike> <strong>